[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582895":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":27,"locations":37,"responsibleParty":71,"collaborators":11,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":9,"officialTitle":9,"acronym":11,"eligibilityCriteria":77,"healthyVolunteers":75,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":11,"studyType":84,"phases":85,"briefSummary":88,"conditions":89,"keywords":98,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"CERM INC.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Autologous Adipose Cells Therapy","EXPERIMENTAL",null,[13],"Biological: Autologous Adipose Cells Therapy",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"BIOLOGICAL","Participants will receive Autologous Adipose Cells therapy treatment, and the safety and efficacy of the treatment will be monitored by the primary investigator up to 25 weeks.",[9],[20,24],{"name":21,"affiliation":22,"role":23},"Dr. Abdollah M. Malekzadeh, MD, MD","The Centre for Cosmetic Surgery & Medicine","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":5,"role":26},"Dr. Arun Kumar, PhD","STUDY_DIRECTOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":11,"email":32},"Ankeet Dixit","CONTACT","813-992-2521","ankeetdixit@cermbio.com",{"name":34,"role":30,"phone":35,"phoneExt":11,"email":36},"Wing Nam Fung","207-671-9370","wingnam@cermbio.com",[38,59],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"The Centre for Cosmetic Surgery & Medicine, Newark","RECRUITING","Lewes","Delaware","19958","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-75.13935,38.77456,{"lat":50,"lon":49},[53,57],{"name":54,"role":30,"phone":55,"phoneExt":11,"email":56},"Dr. Abdollah M. Malekzadeh, MD","302-645-7672","lewes@thecentreforcosmeticsurgery.com",{"name":11,"role":30,"phone":11,"phoneExt":11,"email":58},"abdol@comcast.com",{"facility":22,"status":40,"city":60,"state":42,"zip":61,"country":44,"countryCode":45,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Newark","19713",{"type":47,"coordinates":63},[64,65],-75.74966,39.68372,{"lat":65,"lon":64},[68,70],{"name":54,"role":30,"phone":69,"phoneExt":11,"email":56},"302-994-8492",{"name":11,"role":30,"phone":11,"phoneExt":11,"email":58},{"type":72,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100582895","phase-1-autologous-adipose-cells-therapy-100582895",false,"NCT06869252","Inclusion Criteria:\n\n1. Outpatients who express interest in skin rejuvenation, and\u002For who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.\n2. Outpatients who are experiencing hair loss or hair thinning\n3. Provision of signed and dated informed consent form\n4. Clearly stated willingness to comply with all the procedures of the study and availability of the study\n5. Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor\n\nExclusion Criteria:\n\n1. Pregnancy or lactation\n2. Known allergic reaction to components of cell culture media\n3. Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures\n4. Chronic infections, e.g. skin fungi infection, psoriasis\n5. Chronic wound healing\n6. Currently taking hormone therapy\n7. History of cancers and active cancers\n8. Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.","ALL","21 Years","80 Years",{"count":82,"type":83},40,"ESTIMATED","INTERVENTIONAL",[86,87],"PHASE1","PHASE2","Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.",[90,91,92,93,94,95,96,97],"Hair Loss\u002FBaldness","Wrinkle Appearance","Volume","Fine Lines","Skin Elasticity","Hair Thinning","Skin Pigmentation","Skin Texture",[99,100],"Adipose Cells","Adipocytes","2025-05-30",{"date":103,"type":104},"2025-05-31","ACTUAL",{"date":106,"type":83},"2025-08-01",{"date":108,"type":83},"2026-02-01",{"name":5,"class":6},2]